{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T17:11:04Z","timestamp":1792084264576,"version":"4.4.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[1993,12,1]],"date-time":"1993-12-01T00:00:00Z","timestamp":754704000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[1993,12]]},"DOI":"10.1007\/bf00167234","type":"journal-article","created":{"date-parts":[[2004,11,6]],"date-time":"2004-11-06T06:01:56Z","timestamp":1099720916000},"page":"586-592","source":"Crossref","is-referenced-by-count":67,"title":["The competitive NMDA antagonist CPP protects substantia nigra neurons from MPTP-induced degeneration in primates"],"prefix":"10.1007","volume":"348","author":[{"given":"Klaus W.","family":"Lange","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter-Andreas","family":"L\ufffdschmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emin","family":"Sofic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Burg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reinhard","family":"Horowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl T.","family":"Kalveram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helmut","family":"Wachtel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Riederer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/0014-2999(89)90385-3","volume":"166","author":"J Bormann","year":"1989","unstructured":"Bormann J (1989) Memantine is a potent blocker of N-methyl-d-aspartat (NMDA) receptor channels. Eur J Pharmacol 166:591?592","journal-title":"Eur J Pharmacol"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"4546","DOI":"10.1073\/pnas.80.14.4546","volume":"80","author":"RS Burns","year":"1983","unstructured":"Burns RS, Chiueh CC, Markey SP, Ebert MH, Jacobowitz DM, Kopin IJ (1983) A primate model of parkinsonism; selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Proc Natl Acad Sci USA 80:4546?4550","journal-title":"Proc Natl Acad Sci USA"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0304-3940(90)90131-R","volume":"117","author":"S Carboni","year":"1990","unstructured":"Carboni S, Melis F, Pani L, Hadliconstantinou M, Rossetti Z (1990) The non-competitive NMDA-receptor antagonist MK-801 prevents the massive release of glutamate and aspartate from rat striatum induced by 1-methyl-4-phenylpyridinium (MPP+). Neurosci Lett 117:129?133","journal-title":"Neurosci Lett"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0024-3205(85)90063-3","volume":"36","author":"A Castagnoli Jr","year":"1985","unstructured":"Castagnoli A Jr, Chiba K, Trevor AJ (1985) Potential bioactivation pathways for the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Life Sci 36:225?230","journal-title":"Life Sci"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/0024-3205(87)90297-9","volume":"40","author":"RJ D'Amato","year":"1987","unstructured":"D'Amato RJ, Alexander GM, Schwartzman RJ, Kitt AC, Price DL, Snyder SH (1987) Neuromelanin: a role in MPTP-induced neurotoxicity. Life Sci 40:705?712","journal-title":"Life Sci"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/0165-1781(79)90006-4","volume":"1","author":"GC Davis","year":"1979","unstructured":"Davis GC, Williams AC, Markey SP, Ebert MH, Caine ED, Reichert CM, Kopin IJ (1979) Chronic parkinsonism secondary to intravenous injection of meperidine analogues. Psychiat Res 1:249?254","journal-title":"Psychiat Res"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/j.1476-5381.1988.tb11665.x","volume":"95","author":"TJ Feuerstein","year":"1988","unstructured":"Feuerstein TJ, Hedler L, Jackisch R, Hertting G (1988) An in vitro model of 1-methyl-4-phenyl-pyridinium (MPP+) toxicity: incubation of rabbit caudate nucleus slices with MPP+ followed by biochemical and functional analysis. Br J Pharmacol 95:449?458","journal-title":"Br J Pharmacol"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1471-4159.1984.tb09689.x","volume":"42","author":"F Fonnum","year":"1984","unstructured":"Fonnum F (1984) Glutamate: A neurotransmitter in mammalian brain. J Neurochem 42:1?11","journal-title":"J Neurochem"},{"key":"CR9","first-page":"669","volume":"241","author":"SI Harik","year":"1987","unstructured":"Harik SI, Schmdley JW, Iacofano LA, Blue P, Arora PK, Sayre LM (1987) On the mechanism of underlying 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity: the effects of perinigral infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, its metabolite and their analogs in the rat. J Pharmacol Exp Ther 241:669?676","journal-title":"J Pharmacol Exp Ther"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0306-4522(91)90180-V","volume":"40","author":"M Herkenham","year":"1991","unstructured":"Herkenham M, Little MD, Bankiewicz K, Yang SC, Markey SP, Johannessen JN (1991) Selective retention of MPP+ within the monaminergic system of the primate brain following MPTP administration: an in vivo autoradiographic study. Neuroscience 40:133?158","journal-title":"Neuroscience"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1073\/pnas.82.7.2173","volume":"82","author":"A Javitch","year":"1985","unstructured":"Javitch A, D'Amato RJ, Strittmatter SM, Snyder SH (1985) Parkinsonism inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity. Proc Natl Acad Sci USA 82:2173?2177","journal-title":"Proc Natl Acad Sci USA"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0304-3940(84)90467-1","volume":"50","author":"P Jenner","year":"1984","unstructured":"Jenner P, Rupniak NMJ, Rose S, Kelley E, Kilpatrick G, Lees A, Marsden CD (1984) 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in the common marmoset. Neurosci Lett 50:85?90","journal-title":"Neurosci Lett"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0024-3205(85)90062-1","volume":"36","author":"JN Johannessen","year":"1985","unstructured":"Johannessen JN, Chiueh CC, Burns RS, Markey SP (1985) Differences in metabolism of MPTP in the rodent and primate parallel differences in sensitivity to its neurotoxic effects. Life Sci 36:219","journal-title":"Life Sci"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/0014-2999(89)90384-1","volume":"166","author":"J Kornhuber","year":"1989","unstructured":"Kornhuber J, Bormann J, Retz W, H\u00fcbers M, Riederer P (1989) Memantine displaces [3H]MK-801 at therapeutic concentrations in postmortem human frontal cortex. Eur J Pharmacol 166:589?590","journal-title":"Eur J Pharmacol"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1126\/science.6332378","volume":"225","author":"JW Langston","year":"1983","unstructured":"Langston JW, Ballard B, Tetrud JW, Irwin I (1983) Chronic parkinsonism in humans due to a product of meperidine-analog synthesis. Science 225:1480?1482","journal-title":"Science"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0014-2999(89)90348-8","volume":"166","author":"PA L\u00f6schmann","year":"1989","unstructured":"L\u00f6schmann PA, Chong PN, Nomoto M, Tepper PG, Horn AS, Jenner P, Marsden CD (1989) Stereoselective reversal of MPTP-induced parkinsonism in the marmoset after dermal application of N-0437. Eur J Pharmacol 166:373?380","journal-title":"Eur J Pharmacol"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/BF02259538","volume":"3","author":"PA L\u00f6schmann","year":"1991","unstructured":"L\u00f6schmann PA, Lange KW, Kunow M, Rettig KJ, J\u00e4hnig P, Honor\u00e9 T, Turski L, Wachtel H., Jenner P, Marsden CD (1991) Synergism of the AMPA-antagonist NBQX and the NMDA-antagonist CPP with l-Dopa in models of Parkinson's disease. J Neural Transm [PD Sec] 3:203?213","journal-title":"J Neural Transm [PD Sec]"},{"key":"CR18","first-page":"717","volume":"263","author":"A Lupp","year":"1992","unstructured":"Lupp A, L\u00fccking CH, Koch R, Jackisch R, Feuerstein TJ (1992) Inhibitory effects of the antiparkinsonian drugs memantine and amantadine on N-methyl-D-aspartate-evoked acetylcholine release in the rabbit caudate nucleus in vitro. J Pharmacol Exp Ther 263:717?724","journal-title":"J Pharmacol Exp Ther"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1016\/0024-3205(85)90146-8","volume":"36","author":"WJ Nicklas","year":"1985","unstructured":"Nicklas WJ, Vyas I, Heikkila RE (1985) Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenylpyridine, a metabolite of the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Life Sci 36:2503?2508","journal-title":"Life Sci"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0006-8993(88)90765-2","volume":"451","author":"A Novelli","year":"1988","unstructured":"Novelli A, Reilly JA, Lysko PG, Henneberry RC (1988) Glutamate becomes neurotoxic via the N-methyl-D-aspartate receptor when intracellular energy levels are reduced. Brain Res 451:205?212","journal-title":"Brain Res"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/307462a0","volume":"307","author":"L Nowak","year":"1984","unstructured":"Nowak L, Bregestovski P, Ascher P, Herbet A, Prochiantz A (1984) Magnesium gates glutamate-activated channels in mouse central neurons. Nature 307:462?465","journal-title":"Nature"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1126\/science.164.3880.719","volume":"164","author":"JW Olney","year":"1969","unstructured":"Olney JW (1969) Brain lesions, obesity and other disturbances in mice treated with monosodium glutamate. Science 164:719?721","journal-title":"Science"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/ddr.430170406","volume":"17","author":"JW Olney","year":"1989","unstructured":"Olney JW (1989) Excitotoxicity and N-Methyl-D-aspartate receptors. Drug Dev Res 17:299?319","journal-title":"Drug Dev Res"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1126\/science.2660263","volume":"244","author":"JW Olney","year":"1989","unstructured":"Olney JW, Labruyere J, Price MT (1989) Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs. Science 244:1360?1362","journal-title":"Science"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1126\/science.1835799","volume":"254","author":"JW Olney","year":"1991","unstructured":"Olney JW, Labruyere J, Wang G, Wozniak DF, Price MT, Sesma MA (1991) NMDA antagonist neurotoxicity: mechanism and prevention. Science 254:1515?1518","journal-title":"Science"},{"key":"CR26","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/0006-8993(91)91444-6","volume":"567","author":"I P\u00e9rez-Ota\u00f1o","year":"1991","unstructured":"P\u00e9rez-Ota\u00f1o I, Herrero MT, Oset C, De Ceballos ML, Luquin MR, Obeso JA, Del Rio J (1991) Extensive loss of brain dopamine and serotonin induced by chronic administration of MPTP in the marmoset. Brain Res 567:127?132","journal-title":"Brain Res"},{"key":"CR27","first-page":"858","volume":"245","author":"H Rollema","year":"1988","unstructured":"Rollema H, Kuhr WG, Kranenborg G, DeVries J, Van den Berg C (1988) MPP+ induced efflux of dopamine and lactate from rat striatum have similar time courses as shown by in vivo brain dialysis. J Pharmacol Exp Ther 245:858?866","journal-title":"J Pharmacol Exp Ther"},{"key":"CR28","doi-asserted-by":"crossref","first-page":"3677","DOI":"10.1016\/0006-2952(89)90572-8","volume":"38","author":"S Rose","year":"1989","unstructured":"Rose S, Nomoto M, Jenner P, Marsden CD (1989) Transient depletion of nucleus accumbens dopamine content may contribute to initial akinesia induced by MPTP in common marmosets. Biochem Pharmacol 38:3677?3681","journal-title":"Biochem Pharmacol"},{"key":"CR29","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1111\/j.1471-4159.1988.tb02495.x","volume":"50","author":"S Schinelli","year":"1988","unstructured":"Schinelli S, Zuddas A, Kopin IJ, Barker JL, di Prozio U (1988) 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine and 1-methyl-4-phenylpyridinium uptake in dissociated cell cultures from embryonic mesencephalon. J Neurochem 50:1900?1907","journal-title":"J Neurochem"},{"key":"CR30","unstructured":"Sofic E (1986) Determinations of biogenic amines, metabolites, ascorbic acid and glutathion by HPLC-ECD. Doctoral Thesis, Techn Univ Vienna"},{"key":"CR31","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1126\/science.2563176","volume":"243","author":"PK Sonsalla","year":"1989","unstructured":"Sonsalla PK, Nicklas WJ, Heikkila RE (1989) Role for excitatory amino acids in methamphetamine-induced nigrostriatal dopaminergic toxicity. Science 243:398?400","journal-title":"Science"},{"key":"CR32","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1111\/j.1471-4159.1992.tb10081.x","volume":"58","author":"PK Sonsalla","year":"1992","unstructured":"Sonsalla PK, Zeevalk GD, Manzino L, Giovanni A, Nicklas WJ (1992) MK-801 fails to protect against the dopaminergic neuropathology produced by systemic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice or intranigral 1-methyl-4-phenylpyridinium in rats. J Neurochem 58:1979?1982","journal-title":"J Neurochem"},{"key":"CR33","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1126\/science.3603037","volume":"237","author":"PS Spencer","year":"1987","unstructured":"Spencer PS, Nunn PB, Hugon J, Ludolph AC, Ross SM, Richard DN, Robertson C (1987) Guam amyotrophic lateral sclerosis-parkinson dementia linked to a plant excitant neurotoxin. Science 237:517?522","journal-title":"Science"},{"key":"CR34","volume-title":"The brain of the common marmoset","author":"H Stephan","year":"1980","unstructured":"Stephan H, Baron G, Schwerdtfeger WK (1980) The brain of the common marmoset. Springer, Berlin Heidelberg New York"},{"key":"CR35","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/349414a0","volume":"349","author":"L Turski","year":"1991","unstructured":"Turski L, Bressler K, Rettig KJ, L\u00f6schmann PA, Wachtel H (1991) Protection of substantia nigra from MPP+ neurotoxicity by N-methyl-D-aspartate antagonists: Nature 349:414?418","journal-title":"Nature"},{"key":"CR36","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1111\/j.1471-4159.1992.tb09429.x","volume":"59","author":"A Zuddas","year":"1992","unstructured":"Zuddas A, Oberto G, Vaglini F, Fascetti F, Fornai F, Corsini GU (1992) MK-801 prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in primates. J Neurochem 59:733?739","journal-title":"J Neurochem"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00167234\/fulltext.html","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00167234.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00167234\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00167234","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,3]],"date-time":"2019-04-03T08:14:45Z","timestamp":1554279285000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00167234"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1993,12]]},"references-count":36,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1993,12]]}},"alternative-id":["BF00167234"],"URL":"https:\/\/doi.org\/10.1007\/bf00167234","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[1993,12]]}}}